Left Atrial Appendage Closure: An Alternative to Anticoagulation for Stroke Prevention in Patients with Kidney Disease

12Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Anticoagulation to reduce thromboembolic stroke risk due to nonvalvular atrial fibrillation in ESKD is associated with increased bleeding. There is an existing debate in ESKD centers around the pros and cons of anticoagulation. We propose percutaneous left atrial appendage occlusion as a third alternative to balance thrombosis and bleeding risks in this high-risk population.

Cite

CITATION STYLE

APA

Vallurupalli, S., Sharma, T., Al Aref, S., Devabhaktuni, S. R., & Dhar, G. (2022, February 1). Left Atrial Appendage Closure: An Alternative to Anticoagulation for Stroke Prevention in Patients with Kidney Disease. Kidney360. Lippincott Williams and Wilkins. https://doi.org/10.34067/KID.0004082021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free